Agios Pharmaceuticals reported $88.54M in Cash and Equivalent for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Agios Pharmaceuticals AGIO:US $ 88.54M 8.52M
Alnylam Pharmaceuticals ALNY:US $ 575.56M 41.48M
Amgen AMGN:US $ 5203M 1325M
Arrowhead Research ARWR:US $ 139.44M 53.03M
Astellas Pharma 4503:JP Y 313013M 2973M
AstraZeneca AZN:LN 395649.11M 43092.62M
Bayer BAYN:GR € 3412M 2373M
Biogen BIIB:US $ 2646.6M 897.3M
Biomarin Pharmaceutical BMRN:US $ 619.8M 14.36M
Bluebird Bio BLUE:US $ 81.5M 24.76M
Bristol Myers Squibb BMY:US $ 10750M 1619M
Cerulean Pharma CERU:US $ 39.32M 12.36M
Daiichi Sankyo 4568:JP Y 658064M 4413M
Eli Lilly And LLY:US $ 2622.9M 163.7M
Epizyme EPZM:US $ 71.07M 6.36M
Exelixis EXEL:US $ 627M 96.27M
Gilead Sciences GILD:US $ 7000M 2704M
GlaxoSmithKline GSK:LN 646500M 450200M
Immunogen IMGN:US $ 373.87M 63.79M
IONIS PHARMACEUT IONS:US $ 521.92M 20.6M
Mirati Therapeutics MRTX:US $ 245.51M 47.91M
Moderna Inc MRNA:US 2.87B 2.18B
Nektar Therapeutics NKTR:US $ 77.54M 9.55M
Novartis NOVN:VX SF 3625M 10227M
Novartis NVS:US $ 3625M 10227M
Puma Biotechnology PBYI:US $ 52.76M 11.16M
Regeneron Pharmaceuticals REGN:US $ 3395.1M 49.4M
Sarepta Therapeutics SRPT:US $ 868.56M 365.31M
Seattle Genetics SGEN:US $ 364.87M 103.88M
Vertex Pharmaceuticals VRTX:US $ 8702.2M 1102.1M
YTE INCY:US $ 2435.38M 178.62M